*Consolidated statement of changes in equity
Consolidated statement of changes in equity
| |
Equity attributable to owners of the parent |
|
|
| (in € millions) |
Share capital |
Share premium |
Treasury shares |
Consolidated reserves |
Net income |
Currency translation reserves |
Amounts recognised directly in equity |
Total attributable to owners of the parent |
Non-controlling interests |
Total |
| Balance at 31/12/2023 |
1,473 |
13,407 |
(1,419) |
10,422 |
4,702 |
(91) |
(382) |
28,113 |
3,928 |
32,040 |
| Net income for the period |
- |
- |
- |
- |
4,863 |
- |
- |
4,863 |
410 |
5,274 |
| Other comprehensive income recognised directly in the equity of controlled companies |
- |
- |
- |
- |
- |
31 |
(118) |
(87) |
(154) |
(241) |
| Other comprehensive income recognised directly in the equity of companies accounted for under the equity method |
- |
- |
- |
- |
- |
18 |
(28) |
(9) |
- |
(9) |
| Total comprehensive income for the period |
- |
- |
- |
- |
4,863 |
49 |
(146) |
4,767 |
256 |
5,024 |
| Increase in share capital |
16 |
652 |
- |
- |
- |
- |
- |
668 |
2 |
670 |
| Decrease in share capital |
(35) |
- |
1,495 |
(1,460) |
- |
- |
- |
- |
(3) |
(3) |
| Transactions in treasury shares |
- |
- |
(1,642) |
(270) |
- |
- |
- |
(1,912) |
- |
(1,912) |
| Appropriation of net income and dividend payments |
- |
- |
- |
2,133 |
(4,702) |
- |
- |
(2,570) |
(902) |
(3,472) |
| Share-based payments (IFRS 2) |
- |
- |
- |
344 |
- |
- |
- |
344 |
- |
344 |
| Impact of acquisitions or disposals of non-controlling interests after acquisition of control |
- |
- |
- |
1 |
- |
1 |
- |
2 |
- |
2 |
| Changes in consolidation scope |
- |
- |
- |
25 |
- |
7 |
(32) |
- |
804 |
804 |
| Other |
- |
- |
- |
530 |
- |
1 |
4 |
535 |
1 |
536 |
| Balance at 31/12/2024 |
1,455 |
14,059 |
(1,566) |
11,724 |
4,863 |
(32) |
(555) |
29,947 |
4,085 |
34,032 |
| Net income for the period |
- |
- |
- |
- |
4,903 |
- |
- |
4,903 |
372 |
5,275 |
| Other comprehensive income recognised directly in the equity of controlled companies |
- |
- |
- |
- |
- |
(853) |
331 |
(522) |
(84) |
(606) |
| Other comprehensive income recognised directly in the equity of companies accounted for under the equity method |
- |
- |
- |
- |
- |
(20) |
74 |
54 |
- |
54 |
| Total comprehensive income for the period |
- |
- |
- |
- |
4,903 |
(873) |
405 |
4,435 |
288 |
4,723 |
| Increase in share capital |
19 |
752 |
- |
- |
- |
- |
- |
771 |
11 |
782 |
| Decrease in share capital |
(19) |
- |
511 |
(492) |
- |
- |
- |
- |
- |
- |
| Transactions in treasury shares |
- |
- |
(1,741) |
(261) |
- |
- |
- |
(2,002) |
- |
(2,002) |
| Appropriation of net income and dividend payments |
- |
- |
- |
2,198 |
(4,863) |
- |
- |
(2,665) |
(805) |
(3,469) |
| Share-based payments (IFRS 2) |
- |
- |
- |
422 |
- |
- |
- |
422 |
- |
422 |
| Impact of acquisitions or disposals of non-controlling interests after acquisition of control |
- |
- |
- |
(13) |
- |
(1) |
- |
(14) |
(4) |
(17) |
| Changes in consolidation scope |
- |
- |
- |
16 |
- |
- |
(16) |
- |
(1) |
(1) |
| Other |
- |
- |
- |
(140) |
- |
- |
(3) |
(143) |
- |
(142) |
| Balance at 31/12/2025 |
1,455 |
14,811 |
(2,796) |
13,454 |
4,903 |
(906) |
(168) |
30,752 |
3,576 |
34,328 |